Skip to content

BD Nexiva™ Closed IV Catheter System 383647Recalls & reported problems

Becton, Dickinson And Company · BD Nexiva™ Closed IV Catheter System 20GA x 1.25IN · Class 2

All models of BD Nexiva Closed IV Catheter System (7)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
8
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00382903836475), received between Apr 8, 2024 and May 15, 2026 — classified as 8 malfunctions.

The most frequently reported specific device problem is “Leak/Splash” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 2 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 1 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Leak/Splash3
  • Material Deformation1
  • Material Integrity Problem1
  • Material Rupture1
  • Material Separation1
  • Material Split, Cut or Torn1
  • Separation Failure1

Patient problems

  • No Clinical Signs, Symptoms or Conditions7
  • Extravasation1
  • Insufficient Information1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 15, 2026Material Split, Cut or Torn

    IT WAS REPORTED THAT THE TUBING BROKE. 20G NEXIVA DUAL PORT INSERTED THE MORNING OF THE 29TH OF APRIL, PATIENT HAD A SHOWER AND HAD A PLASTIC SHOWER SLEEVE INSITU. WHEN SHOWER SLEEVE REMOVED, BLOOD NOTICED, NEXIVA EXTENSION SET WAS IN 2 PIECES, SLICED DIRECTLY ACROSS. UNKNOWN AS TO HOW.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25188571 ↗
  • MalfunctionDec 31, 2025Leak/Splash; Leak/Splash

    IT WAS REPORTED THAT BD NEXIVA 20GA 1.25IN HF Y W/ CAP LEAKAGE AT CATHETER JUNCTION WHEN IN USE, THE EXTENSION TUBING LEAKED AT THE CONNECTION TO THE CATHETER ADAPTER, DEFECTIVE QUANTITY 1, UNABLE TO RETURN DEFECTIVE PRODUCT, NO PHOTOS PROVIDED. CLAIMS NEED TO BE SETTLED, COMPLAINT RESPONSE LETTER NEEDED, COMPLAINT RECEIPT LETTER NEEDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23935474 ↗
  • MalfunctionAug 20, 2025Material Deformation; Material Deformation

    NO NEW INFORMATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22848918 ↗
  • MalfunctionAug 1, 2025Material Integrity Problem; Material Integrity Problem

    NO NEW INFORMATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22690117 ↗
  • MalfunctionDec 13, 2024Leak/Splash; Separation Failure; Leak/Splash; Separation Failure

    IT WAS REPORTED THAT LEAKAGE AT SEPTUM AND DIFFICULTY WITHDRAWING NEEDLE CORE OCCURRED. ON (B)(6) 2025 CUSTOMER RESPONSE: BLOOD LEAKS FROM THE ISOLATION WHERE THE NEEDLE CORE IS WITHDRAWN AND THE NEEDLE TIP GUARD CANNOT BE ACTIVATED.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 20925627 ↗
  • MalfunctionOct 21, 2024Material Rupture; Material Rupture

    22-OCT-2024: RECEIVED AN EMAIL RESPONSE FROM COMPLAINANT FOR INFORMATION. IN REFERENCE TO DOT POINT 1: THE PATIENT HAD SOFT TISSUE DAMAGE AS THE VEIN BLEW - THIS BEING THE INDICATION OF A VEIN EXTRAVASATION. IT IS WHERE THE CONTENT OF CONTRAST/N SALINE LEAKS INTO THE SURROUNDING TISSUES AND FORM A RAISED LUMP. IN REFERENCE TO DOT POINT 2: THE CLAMP WAS UNCLAMPED. THIS IS TESTED AND ENSURED PRIOR TO SCAN. THIS ALSO IS SUPPORTED BY THE VEIN EXTRAVASATION. WITH THIS, THE PRESSURE THE RADIOGRAPHER SET FOR CONTRAST INJECTION MAY HAVE BREACHED THE LINES LIMIT. IN REFERENCE TO DOT POINT 3: SEE REFERENCE TO DOT POINT 1 AS BOTH COME UNDER THE SAME CATEGORY. WITH THIS INCIDENT CONTRAST WAS ALSO NOTED ON THE SURFACE OF THE PATIENTS SKIN AS WELL. IN TOTAL: VISUAL OUTSIDE SKIN WAS NOTED WITH LEAKED CONTRAST, AND INTERNAL SOFT TISSUE DAMAGE (EXTRAVASATION) IN ADDITION WITH THE BLOWN EXTENSION LINE AS NOTED BY THE PICTURES AND REPORT.

    Patient problems: Extravasation

    MAUDE report 20495635 ↗
  • MalfunctionAug 27, 2024Leak/Splash; Leak/Splash

    IT WAS REPORTED THAT BD NEXIVA LEAKED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM CHINESE TO ENGLISH: WHEN USED IN THE RADIOTHERAPY DEPARTMENT, THE INFUSION CONNECTOR LEAKED AND THE DEFECTIVE PRODUCT COULD NOT BE RETURNED, A CLAIM WAS REQUIRED, A COMPLAINT RESPONSE LETTER WAS REQUIRED, AND A COMPLAINT RECEIPT LETTER WAS REQUIRED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20081091 ↗
  • MalfunctionApr 8, 2024Material Separation; Material Separation

    CANULLA AS INSERTED IN PATIENT 3 DAYS AGO, THE NEXIVA FLEXIBLE TUBING HAS SEPARATED FROM THE WINGS OF THE CANNULA.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19066387 ↗

Other Catheter, intravascular, therapeutic, short-term less than 30 days devices

All Catheter, intravascular, therapeutic, short-term less than 30 days devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page